News & Announcements
February 7, 2008 — Dr. Guido Tricot (pictured at right), director of the Utah Blood/Marrow Transplant and Myeloma Program here at the University of Utah, was recently featured in the University's Pulse newsletter in an article highlighting a new treatment for patients with multiple myeloma which increases the survival rate from 2.5 to 10 years. Dr. Tricot was also featured on local TV station KTVX's Good Things Utah in an interview airing Thursday February 7, 2008.
January 2, 2008 — Dr. Maurizio Zangari joins the Blood/Marrow Transplant and Myeloma Program as Director of Experimental Therapeutics. Dr. Zangari has over two decades of experience in cancer treatment and research.
October 17, 2007 — Dr. George Rodgers, a hematologist specializing in bleeding disorders here at the University of Utah, was interviewed on KUTV about von Willebrand disease, a relatively common inherited bleeding disorder affecting as many as 1 in 100 people.
September 1, 2007 — This year marks our third year as a Center of Excellence in Molecular Hematology (CEMH). The CEMH supports research to identify genes and pathways involved in heme and metal metabolism. For more information visit the University of Utah CEMH website.